Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-1,000
Closed -$34.5K 701
2019
Q2
$34.5K Hold
1,000
0.01% 408
2019
Q1
$80.5K Buy
+1,000
New +$12.9K 0.02% 317
2015
Q4
Sell
-5,500
Closed -$2.21M 568
2015
Q3
$2.21M Buy
5,500
+2,000
+57% +$10.2K 0.28% 63
2015
Q2
$1.31M Sell
3,500
-3,000
-46% -$20.1K 0.14% 79
2015
Q1
$1.33M Buy
6,500
+5,250
+420% +$38.1K 0.15% 78
2014
Q4
$855K Buy
+1,250
New +$11.7K 0.12% 105

Other funds holding VALE

Exane Derivatives's VALE Position: Q2 2022 in Review

Exane Derivatives sold out of Vale (VALE) in Q2 2022, closing a stake of 117,076 shares — an estimated $2.34M sold.

Exane Derivatives first reported a position in VALE in Q1 2015 and held it in 19 quarters. The position peaked at $11M in Q1 2017. 484 funds tracked by Wall St. Rank hold VALE as of Q2 2022.

  • Exane Derivatives reported no remaining Vale position as of Q2 2022 after selling out during the quarter.
  • Exane Derivatives sold 117,076 Vale shares in Q2 2022, an estimated $2.34M.
  • Exane Derivatives first reported a position in Vale in Q1 2015 and held it in 19 quarters.
  • Exane Derivatives's Vale position peaked at $11M in Q1 2017.
  • 484 funds tracked by Wall St. Rank held Vale as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.